Lumos Diagnostics Holdings Limited (LDXHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -5.43 Million USD | -10.29% |
| 2023 | -4.92 Million USD | 65.51% |
| 2022 | -40.23 Million USD | -75.06% |
| 2021 | -10.47 Million USD | -5.19% |
| 2020 | -10.41 Million USD | -310.68% |
| 2019 | -2.46 Million USD | -105.93% |
| 2018 | -1.19 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - USD | 20.89% |
| 2024 Q1 | -2.19 Million USD | -1422.18% |
| 2024 Q2 | -4.57 Million USD | -108.68% |
| 2024 Q3 | -691.33 Thousand USD | 84.88% |
| 2024 Q4 | -842.25 Thousand USD | -21.83% |
| 2023 Q4 | -2.26 Million USD | -62.39% |
| 2023 FY | - USD | 65.51% |
| 2023 Q3 | -1.39 Million USD | 67.88% |
| 2023 Q2 | -4.34 Million USD | -124.5% |
| 2023 Q1 | -1.93 Million USD | 82.85% |
| 2022 Q4 | -11.27 Million USD | 0.0% |
| 2022 FY | - USD | -75.06% |
| 2022 Q2 | -9.69 Million USD | 0.0% |
| 2021 Q4 | -8.41 Million USD | 0.0% |
| 2021 Q2 | -2.78 Million USD | 0.0% |
| 2021 FY | - USD | -5.19% |
| 2020 Q2 | -3.9 Million USD | 0.0% |
| 2020 Q4 | -6.86 Million USD | 0.0% |
| 2020 FY | - USD | -310.68% |
| 2019 FY | - USD | -105.93% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -367.412% |
| Arrayit Corporation | -3.07 Million USD | -76.637% |
| Atlantic International Corp. | -5.38 Million USD | -0.862% |
| Biocept, Inc. | -30.24 Million USD | 82.024% |
| Bioqual, Inc. | 3.03 Million USD | 279.273% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -617.742% |
| DermTech, Inc. | -97.89 Million USD | 94.447% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.187% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 73.146% |
| iMD Companies, Inc. | -154.65 Thousand USD | -3414.829% |
| IDenta Corp. | 71.58 Thousand USD | 7693.557% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 241.673% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 14150.142% |
| InVitro International | 6680.00 USD | 81477.246% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -44699.736% |
| Medical Imaging Corp. | -896.74 Thousand USD | -506.194% |
| NovelStem International Corp. | -3.78 Million USD | -43.589% |
| Optigenex Inc. | -1.18 Million USD | -358.068% |
| PharmChem, Inc. | 1.05 Million USD | 615.843% |
| Proteome Sciences plc | -1.13 Million USD | -378.1% |
| Response Genetics, Inc | -19.66 Million USD | 72.358% |
| Rennova Health, Inc. | -234.81 Thousand USD | -2215.014% |
| RushNet, Inc. | -614.85 Thousand USD | -784.115% |
| ScreenPro Security Inc. | -3.43 Million USD | -58.258% |
| Stella Diagnostics Inc. | -5.7 Million USD | 4.756% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 47.07% |
| Todos Medical Ltd. | -9.39 Million USD | 42.133% |